<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Referencing Approved Drug Products in Abbreviated New Drug Application Submissions; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Referencing Approved Drug Products in Abbreviated New Drug Application Submissions; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2017-01-17 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Referencing Approved Drug Products in ANDA Submissions." Any person is permitted to submit an abbreviated new drug application (ANDA) in order to seek approval to market a generic version of a previously approved drug product. The purpose of this guidance is to provide information to potential applicants on how to identify a reference listed drug (RLD), reference standard, a...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2017-00820</p>
    <p><strong>Publication Date:</strong> 2017-01-17</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2017/01/17/2017-00820/referencing-approved-drug-products-in-abbreviated-new-drug-application-submissions-draft-guidance">https://www.federalregister.gov/documents/2017/01/17/2017-00820/referencing-approved-drug-products-in-abbreviated-new-drug-application-submissions-draft-guidance</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2017-00820</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
